Vitrosens Biotechnology is a multi platform diagnostic manufacturer developing integrated rapid, immunofluorescence, and molecular systems for global human and animal health.
Vitrosens combines manufacturing depth, regulatory leadership, and multidisciplinary engineering to create integrated platforms across rapid, immunofluorescence, molecular, and emerging technologies. From Istanbul, we support healthcare systems worldwide with scalable and resilient diagnostic infrastructure.
Vitrosens operates Turkiye’s largest rapid diagnostic production facility, forming the foundation of our integrated multi platform strategy. Designed for high volume manufacturing and international distribution, our infrastructure supports rapid assays, immunofluorescence systems, and molecular diagnostic solutions under disciplined quality systems.
As the first IVD manufacturer in Turkiye to obtain MDSAP certification, Vitrosens established a regulatory framework aligned with major global authorities. This infrastructure enables scalable production, international market access, and long term partnership stability across human and animal health.
Capabilities structured to support long-term international partnerships.
Multidisciplinary teams across molecular biology, immunology, biochemistry, and assay development design and validate diagnostic systems across rapid, immunofluorescence, and molecular platforms.
Semi-automated and automated production lines designed to ensure consistency, traceability, and scalable output across high-volume manufacturing environments.
Vitrosens operates under ISO 13485 certified quality management systems and was the first IVD manufacturer in Turkiye to obtain MDSAP certification, audited by SGS. This framework aligns manufacturing processes with major regulatory authorities and supports international market access.
Positioned at the crossroads of Europe, Asia, and the Middle East, enabling rapid distribution to global markets with unmatched efficiency.
More than 300 validated diagnostic products across infectious diseases, cardiac markers, oncology, drug screening, and veterinary diagnostics, structured within scalable platform architecture.
Private label manufacturing and custom assay development designed to support regulatory pathways, localized market requirements, and long-term distribution partnerships.
Structured across rapid, quantitative, molecular, and specialized testing systems.
Rapid lateral flow platforms designed for qualitative and semi-quantitative detection across decentralized clinical settings.
Quantitative immunofluorescence systems utilizing Europium-based time-resolved detection for enhanced sensitivity and reproducible performance.
PCR-based molecular platforms engineered for precise pathogen detection and quantitative analysis.
Freeze-dried molecular reagent systems developed for extended stability and simplified distribution at controlled or room temperatures.
Integrated automation and robotic platforms designed to standardize workflows, enhance reproducibility, and support scalable deployment across diagnostic applications.
Self-testing and digital diagnostic platforms developed for over-the-counter use, combining reliable assay performance with connected health integration.
Multi-panel rapid detection systems developed for clinical, workplace, and regulatory substance testing programs.
Comprehensive diagnostic platforms spanning infectious disease, metabolic assessment, cardiac markers, oncology, and routine screening across companion and livestock animal health
Join 250+ partners worldwide who trust Vitrosens for innovative, reliable diagnostic solutions that transform healthcare delivery
Start Partnership
